Free Trial

OSR (OSRH) Competitors

OSR logo
$1.41 -0.22 (-13.50%)
As of 06/13/2025 03:59 PM Eastern

OSRH vs. MBOT, GUTS, MGRM, FONR, PTHL, NTRB, INO, SRTS, NSPR, and TELA

Should you be buying OSR stock or one of its competitors? The main competitors of OSR include Microbot Medical (MBOT), Fractyl Health (GUTS), Monogram Orthopaedics (MGRM), FONAR (FONR), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), Nutriband (NTRB), Inovio Pharmaceuticals (INO), Sensus Healthcare (SRTS), InspireMD (NSPR), and TELA Bio (TELA). These companies are all part of the "medical equipment" industry.

OSR vs. Its Competitors

OSR (NASDAQ:OSRH) and Microbot Medical (NASDAQ:MBOT) are both small-cap manufacturing companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, community ranking, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

OSR has higher earnings, but lower revenue than Microbot Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OSR-$148.95K-182.48N/AN/AN/A
Microbot MedicalN/AN/A-$10.74M-$0.65-3.60

OSR's return on equity of 0.00% beat Microbot Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
OSRN/A N/A N/A
Microbot Medical N/A -218.30%-158.17%

Microbot Medical received 349 more outperform votes than OSR when rated by MarketBeat users.

CompanyUnderperformOutperform
OSRN/AN/A
Microbot MedicalOutperform Votes
349
70.65%
Underperform Votes
145
29.35%

55.3% of OSR shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 33.7% of OSR shares are held by insiders. Comparatively, 4.7% of Microbot Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Microbot Medical had 15 more articles in the media than OSR. MarketBeat recorded 16 mentions for Microbot Medical and 1 mentions for OSR. OSR's average media sentiment score of 1.87 beat Microbot Medical's score of 0.88 indicating that OSR is being referred to more favorably in the media.

Company Overall Sentiment
OSR Very Positive
Microbot Medical Positive

Microbot Medical has a consensus target price of $9.00, suggesting a potential upside of 284.62%. Given Microbot Medical's stronger consensus rating and higher probable upside, analysts plainly believe Microbot Medical is more favorable than OSR.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OSR
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Microbot Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

OSR has a beta of 1.61, suggesting that its share price is 61% more volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500.

Summary

OSR and Microbot Medical tied by winning 6 of the 12 factors compared between the two stocks.

Get OSR News Delivered to You Automatically

Sign up to receive the latest news and ratings for OSRH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OSRH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OSRH vs. The Competition

MetricOSRHolding Offices IndustryManufacturing SectorNASDAQ Exchange
Market Cap$27.18M$482.13M$2.02B$8.51B
Dividend YieldN/A7.68%2.62%4.15%
P/E RatioN/A2.5022.5519.65
Price / Sales-182.4880.1653.57152.18
Price / CashN/A69.0151.7234.64
Price / BookN/A6.282.104.59
Net IncomeN/A$35.76M-$292.00M$248.23M
7 Day Performance3.68%2.39%-0.44%-1.07%
1 Month Performance20.51%2.80%3.72%3.35%
1 Year PerformanceN/A45.25%20.63%13.77%

OSR Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OSRH
OSR
N/A$1.41
-13.5%
N/AN/A$27.18M-$148.95K0.00N/APositive News
Gap Down
MBOT
Microbot Medical
1.9349 of 5 stars
$2.81
+4.9%
$9.00
+220.3%
+116.7%$102.22MN/A-3.5120News Coverage
Analyst Upgrade
Analyst Revision
Gap Down
GUTS
Fractyl Health
2.2979 of 5 stars
$1.99
+2.6%
$11.00
+452.8%
-65.2%$97.46M$60K-0.16102News Coverage
Positive News
MGRM
Monogram Orthopaedics
2.9165 of 5 stars
$2.54
+0.8%
$5.40
+112.6%
+27.9%$90.65M$365.00K-5.4028Positive News
FONR
FONAR
1.2842 of 5 stars
$14.48
-0.1%
N/A-3.0%$89.82M$103.02M12.59480News Coverage
Positive News
Short Interest ↑
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
N/A$13.50
+51.7%
N/AN/A$88.86M$448.20K0.0011Positive News
Gap Down
High Trading Volume
NTRB
Nutriband
2.2698 of 5 stars
$7.70
+6.1%
$13.00
+68.8%
+19.2%$85.89M$2.40M-10.8410
INO
Inovio Pharmaceuticals
3.9884 of 5 stars
$2.27
+7.1%
$9.75
+329.5%
-78.8%$83.25M$283.10K-0.71320Positive News
Analyst Downgrade
SRTS
Sensus Healthcare
2.4479 of 5 stars
$4.92
-2.2%
$11.67
+137.1%
-10.6%$80.91M$39.49M12.3040Positive News
Analyst Upgrade
NSPR
InspireMD
2.4798 of 5 stars
$2.50
flat
$4.50
+80.0%
-10.8%$76.59M$7.03M-3.3350News Coverage
High Trading Volume
TELA
TELA Bio
2.3626 of 5 stars
$1.89
-3.1%
$7.25
+283.6%
-69.3%$74.76M$71.22M-1.12120Analyst Downgrade

Related Companies and Tools


This page (NASDAQ:OSRH) was last updated on 6/14/2025 by MarketBeat.com Staff
From Our Partners